$RCKT
ROCKET PHARMACEUTICALS, INC.

2021 Q4 Form 10-K Financial Statement

#000114036122007036 Filed on February 28, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $12.17M $41.77M $8.200M
YoY Change 48.44% 49.61% 64.66%
% of Gross Profit
Research & Development $32.16M $125.5M $51.04M
YoY Change -36.99% 19.0% 247.92%
% of Gross Profit
Depreciation & Amortization $3.185M $5.373M $630.0K
YoY Change 405.56% 388.45% 530.0%
% of Gross Profit
Operating Expenses $44.33M $167.2M $59.24M
YoY Change -25.16% 24.53% 201.48%
Operating Profit -$167.2M -$59.24M
YoY Change 24.53% 201.48%
Interest Expense $387.0K $2.977M -$1.400M
YoY Change -127.64% -57.27% 211.11%
% of Operating Profit
Other Income/Expense, Net -$301.0K -$1.912M -$270.0K
YoY Change 11.48% 229.66% -208.0%
Pretax Income -$44.25M -$169.1M -$60.92M
YoY Change -27.37% 21.02% 206.75%
Income Tax
% Of Pretax Income
Net Earnings -$44.25M -$169.1M -$60.92M
YoY Change -27.36% 21.02% 206.8%
Net Earnings / Revenue
Basic Earnings Per Share -$2.67
Diluted Earnings Per Share -$686.5K -$2.67 -$1.082M
COMMON SHARES
Basic Shares Outstanding 64.44M 63.24M 55.23M
Diluted Shares Outstanding 63.24M

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $388.7M $388.7M $482.7M
YoY Change -19.47% -19.47% 58.73%
Cash & Equivalents $232.7M $232.7M $297.1M
Short-Term Investments $156.0M $156.0M $185.6M
Other Short-Term Assets $3.319M $3.319M $4.600M
YoY Change -27.85% -27.85% 27.78%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $392.1M $392.1M $487.3M
YoY Change -19.55% -19.54% 58.36%
LONG-TERM ASSETS
Property, Plant & Equipment $22.30M $72.35M $19.21M
YoY Change 16.1% 2.48% -34.94%
Goodwill $30.82M $30.82M
YoY Change 0.0% 0.0%
Intangibles $0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.798M $1.798M $2.000M
YoY Change -10.1% -10.1% 0.0%
Total Long-Term Assets $105.0M $105.0M $103.5M
YoY Change 1.43% 1.41% 60.76%
TOTAL ASSETS
Total Short-Term Assets $392.1M $392.1M $487.3M
Total Long-Term Assets $105.0M $105.0M $103.5M
Total Assets $497.0M $497.0M $590.8M
YoY Change -15.88% -15.87% 58.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $20.00M $20.00M $25.30M
YoY Change -20.96% -20.96% 40.56%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.689M $1.689M $6.500M
YoY Change -74.02% -74.02%
Total Short-Term Liabilities $22.17M $22.17M $32.62M
YoY Change -32.04% -32.0% 78.15%
LONG-TERM LIABILITIES
Long-Term Debt $19.14M $19.14M $54.10M
YoY Change -64.61% -64.61% 20.22%
Other Long-Term Liabilities $80.00K $985.0K $136.0K
YoY Change -41.18% 64.17% 491.3%
Total Long-Term Liabilities $80.00K $20.13M $136.0K
YoY Change -41.18% -63.2% 491.3%
TOTAL LIABILITIES
Total Short-Term Liabilities $22.17M $22.17M $32.62M
Total Long-Term Liabilities $80.00K $20.13M $136.0K
Total Liabilities $42.30M $42.30M $87.31M
YoY Change -51.55% -51.55% 34.68%
SHAREHOLDERS EQUITY
Retained Earnings -$491.9M -$322.8M
YoY Change 52.37% 76.28%
Common Stock $645.0K $610.0K
YoY Change 5.74% 11.31%
Preferred Stock
YoY Change
Treasury Stock (at cost) $0.00
YoY Change
Treasury Stock Shares $0.00
Shareholders Equity $454.7M $454.7M $503.5M
YoY Change
Total Liabilities & Shareholders Equity $497.0M $497.0M $590.8M
YoY Change -15.88% -15.87% 58.77%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income -$44.25M -$169.1M -$60.92M
YoY Change -27.36% 21.02% 206.8%
Depreciation, Depletion And Amortization $3.185M $5.373M $630.0K
YoY Change 405.56% 388.45% 530.0%
Cash From Operating Activities -$30.94M -$121.2M -$13.11M
YoY Change 136.01% 62.33% -33.55%
INVESTING ACTIVITIES
Capital Expenditures -$2.042M $7.620M -$14.92M
YoY Change -86.31% -63.02% 61.3%
Acquisitions
YoY Change
Other Investing Activities $18.91M $26.57M -$39.54M
YoY Change -147.81% -139.34% -220.66%
Cash From Investing Activities $16.86M $18.85M -$54.46M
YoY Change -130.97% -119.52% -331.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$11.33M
YoY Change 355.63%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.136M 37.68M 282.4M
YoY Change -99.6% -86.68% 205.64%
NET CHANGE
Cash From Operating Activities -30.94M -121.2M -13.11M
Cash From Investing Activities 16.86M 18.85M -54.46M
Cash From Financing Activities 1.136M 37.68M 282.4M
Net Change In Cash -12.94M -64.63M 214.9M
YoY Change -106.02% -157.83% 123.36%
FREE CASH FLOW
Cash From Operating Activities -$30.94M -$121.2M -$13.11M
Capital Expenditures -$2.042M $7.620M -$14.92M
Free Cash Flow -$28.90M -$128.8M $1.810M
YoY Change -1696.63% 35.21% -117.27%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001281895
CY2021 dei Auditor Firm
AuditorFirmId
274
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
CY2020Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
1568000
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-36829
CY2021 dei Entity Registrant Name
EntityRegistrantName
Rocket Pharmaceuticals, Inc.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-3475813
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
9 Cedarbrook Drive
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Cranbury
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
08512
CY2021 dei City Area Code
CityAreaCode
609
CY2021 dei Local Phone Number
LocalPhoneNumber
659-8001
CY2021 dei Trading Symbol
TradingSymbol
RCKT
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
1900000000
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
64505889
CY2021 dei Auditor Name
AuditorName
EISNERAMPER LLP
CY2021 dei Auditor Location
AuditorLocation
Iselin, New Jersey
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
232694000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
297098000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
156046000
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
185621000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3319000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4626000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
392059000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
487345000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22299000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19206000
CY2021Q4 us-gaap Goodwill
Goodwill
30815000
CY2020Q4 us-gaap Goodwill
Goodwill
30815000
CY2021Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
1343000
CY2021Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
455000
CY2020Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
455000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1569000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
914000
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
48480000
CY2020Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
50521000
CY2021Q4 us-gaap Assets
Assets
497020000
CY2020Q4 us-gaap Assets
Assets
590824000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
19615000
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
25472000
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0
CY2020Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
4875000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
863000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
626000
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1689000
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1644000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
22167000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
32617000
CY2021Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0
CY2020Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
35066000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
905000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
498000
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
19144000
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
18988000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
80000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
136000
CY2021Q4 us-gaap Liabilities
Liabilities
42296000
CY2020Q4 us-gaap Liabilities
Liabilities
87305000
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
64505889
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
64505889
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
60996367
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
60996367
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
645000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
610000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
946152000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
825794000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-161000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-42000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-491912000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-322843000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
28865000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
125476000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
590824000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
105438000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
57907000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
454724000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41772000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
503519000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
497020000
CY2021 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-2912000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18244000
CY2021 us-gaap Operating Expenses
OperatingExpenses
167248000
CY2020 us-gaap Operating Expenses
OperatingExpenses
134303000
CY2019 us-gaap Operating Expenses
OperatingExpenses
76151000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-167248000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-134303000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-76151000
CY2021 rckt Research And Development Incentives
ResearchAndDevelopmentIncentives
1000000
CY2020 rckt Research And Development Incentives
ResearchAndDevelopmentIncentives
0
CY2019 rckt Research And Development Incentives
ResearchAndDevelopmentIncentives
250000
CY2021 us-gaap Interest Expense
InterestExpense
2977000
CY2020 us-gaap Interest Expense
InterestExpense
6967000
CY2019 us-gaap Interest Expense
InterestExpense
5958000
CY2021 us-gaap Interest And Other Income
InterestAndOtherIncome
3068000
CY2020 us-gaap Interest And Other Income
InterestAndOtherIncome
2150000
CY2019 us-gaap Interest And Other Income
InterestAndOtherIncome
3414000
CY2020 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-580000
CY2019 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1175000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-169069000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-139700000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-77270000
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.67
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.67
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.52
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.52
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.58
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.58
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63235417
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63235417
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55380740
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55380740
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49010358
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49010358
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-169069000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-139700000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-77270000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-119000
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-62000
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
147000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-169188000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-139762000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-77123000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
194037000
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
177760000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
31000
CY2019 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
726000
CY2019 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
344000
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
147000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13371000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-77270000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
307297000
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
280763000
CY2019 rckt Treasury Stock Issued During Period Value Stock Options Exercised
TreasuryStockIssuedDuringPeriodValueStockOptionsExercised
-397000
CY2019 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
0
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2558000
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
7629000
CY2020 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
26562000
CY2020 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
72000
CY2020 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
591000
CY2020 rckt Treasury Stock Issued During Period Value Stock Options Exercised
TreasuryStockIssuedDuringPeriodValueStockOptionsExercised
-614000
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-62000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18567000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-139700000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
503519000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11327000
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
40694000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
26354000
CY2021 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
12781000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-119000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
29237000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-169069000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
454724000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-169069000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-139700000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-77270000
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
753000
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2758000
CY2019 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3602000
CY2021 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
3240000
CY2020 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
1145000
CY2019 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
426000
CY2021 rckt Adjustment Of Right Of Use Assets
AdjustmentOfRightOfUseAssets
2133000
CY2020 rckt Adjustment Of Right Of Use Assets
AdjustmentOfRightOfUseAssets
5105000
CY2019 rckt Adjustment Of Right Of Use Assets
AdjustmentOfRightOfUseAssets
0
CY2021 rckt Property Plant And Equipment Write Down
PropertyPlantAndEquipmentWriteDown
261000
CY2020 rckt Property Plant And Equipment Write Down
PropertyPlantAndEquipmentWriteDown
419000
CY2019 rckt Property Plant And Equipment Write Down
PropertyPlantAndEquipmentWriteDown
0
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
29237000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
18567000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
13371000
CY2021 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
12781000
CY2020 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
26562000
CY2019 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
0
CY2021 rckt Accretion Amortization Of Discounts And Premiums Excluding Accretion Income Related To Cash Equivalents Investments
AccretionAmortizationOfDiscountsAndPremiumsExcludingAccretionIncomeRelatedToCashEquivalentsInvestments
-2887000
CY2020 rckt Accretion Amortization Of Discounts And Premiums Excluding Accretion Income Related To Cash Equivalents Investments
AccretionAmortizationOfDiscountsAndPremiumsExcludingAccretionIncomeRelatedToCashEquivalentsInvestments
-580000
CY2019 rckt Accretion Amortization Of Discounts And Premiums Excluding Accretion Income Related To Cash Equivalents Investments
AccretionAmortizationOfDiscountsAndPremiumsExcludingAccretionIncomeRelatedToCashEquivalentsInvestments
1066000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1307000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1517000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
917000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4827000
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
11015000
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2722000
CY2021 rckt Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-11000
CY2020 rckt Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-139000
CY2019 rckt Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-87000
CY2021 rckt Increase Decrease In Finance Lease Liabilities
IncreaseDecreaseInFinanceLeaseLiabilities
201000
CY2020 rckt Increase Decrease In Finance Lease Liabilities
IncreaseDecreaseInFinanceLeaseLiabilities
452000
CY2019 rckt Increase Decrease In Finance Lease Liabilities
IncreaseDecreaseInFinanceLeaseLiabilities
0
CY2021 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-56000
CY2020 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
113000
CY2019 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
0
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-121163000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-74640000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-64663000
CY2021 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
245875000
CY2020 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
209343000
CY2019 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
184298000
CY2021 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
272443000
CY2020 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
141811000
CY2019 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
168556000
CY2021 rckt Payments To Acquire Right Of Use Asset
PaymentsToAcquireRightOfUseAsset
95000
CY2020 rckt Payments To Acquire Right Of Use Asset
PaymentsToAcquireRightOfUseAsset
8452000
CY2019 rckt Payments To Acquire Right Of Use Asset
PaymentsToAcquireRightOfUseAsset
0
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7620000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20607000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
23269000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
18853000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-96591000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39011000
CY2021 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
26354000
CY2020 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
280763000
CY2019 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
177760000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
11327000
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2558000
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
31000
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
CY2020 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
72000
CY2019 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
CY2021 us-gaap Proceeds From Sale Of Treasury Stock
ProceedsFromSaleOfTreasuryStock
0
CY2020 us-gaap Proceeds From Sale Of Treasury Stock
ProceedsFromSaleOfTreasuryStock
591000
CY2019 us-gaap Proceeds From Sale Of Treasury Stock
ProceedsFromSaleOfTreasuryStock
344000
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
CY2021 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
40694000
CY2020 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
7629000
CY2019 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
20179000
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0
CY2021 rckt Reclassification Of Construction In Process To Finance Right Of Use Asset
ReclassificationOfConstructionInProcessToFinanceRightOfUseAsset
98000
CY2020 rckt Reclassification Of Construction In Process To Finance Right Of Use Asset
ReclassificationOfConstructionInProcessToFinanceRightOfUseAsset
26465000
CY2019 rckt Reclassification Of Construction In Process To Finance Right Of Use Asset
ReclassificationOfConstructionInProcessToFinanceRightOfUseAsset
0
CY2021 us-gaap Interest Paid Net
InterestPaidNet
148000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
2960000
CY2020 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
614000
CY2019 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
344000
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
CY2020 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
237000
CY2019 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
37681000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
282989000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
177791000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-64629000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
111758000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
74117000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
298666000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
186908000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
112791000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
234037000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
298666000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
186908000
CY2021 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
728000
CY2020 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
1756000
CY2019 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
4650000
CY2021 rckt Retirement Of Treasury Stock Noncash
RetirementOfTreasuryStockNoncash
0
CY2020 rckt Retirement Of Treasury Stock Noncash
RetirementOfTreasuryStockNoncash
0
CY2019 rckt Retirement Of Treasury Stock Noncash
RetirementOfTreasuryStockNoncash
1393000
CY2021 rckt Treasury Stock Purchases Paid In Prior Year
TreasuryStockPurchasesPaidInPriorYear
0
CY2020 rckt Treasury Stock Purchases Paid In Prior Year
TreasuryStockPurchasesPaidInPriorYear
0
CY2019 rckt Treasury Stock Purchases Paid In Prior Year
TreasuryStockPurchasesPaidInPriorYear
726000
CY2021 rckt Withholding Tax Payable On Shares Withheld In Treasury Stock
WithholdingTaxPayableOnSharesWithheldInTreasuryStock
0
CY2020 rckt Withholding Tax Payable On Shares Withheld In Treasury Stock
WithholdingTaxPayableOnSharesWithheldInTreasuryStock
0
CY2019 rckt Withholding Tax Payable On Shares Withheld In Treasury Stock
WithholdingTaxPayableOnSharesWithheldInTreasuryStock
53000
CY2021 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-119000
CY2020 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-62000
CY2019 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
147000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
2990000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
CY2020 rckt Grant Funds Offset Against Research And Development Expenses
GrantFundsOffsetAgainstResearchAndDevelopmentExpenses
3600000
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
26000
CY2021 rckt Number Of Clinical Stage Programs
NumberOfClinicalStagePrograms
3
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-491900000
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<div style="display:none;"><br/></div> <div style="text-align: left; text-indent: 27pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Use of Estimates</div> <div><br/> </div> <div style="display:none;"><br/></div> <div style="text-align: left; text-indent: 27pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The preparation of the consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions reflected in these consolidated financial statements include but are not limited to goodwill impairment, the accrual of research and development expenses, the valuation of equity transactions, and stock-based awards. Changes in estimates and assumptions are reflected in reported results in the period in which they become known. Actual results could differ from those estimates.</div>
CY2021Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
388700000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
232694000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
297098000
CY2021Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
1343000
CY2020Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
1568000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
234037000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
298666000
CY2021 rckt Grant Funds Offset Against Research And Development Expenses
GrantFundsOffsetAgainstResearchAndDevelopmentExpenses
100000
CY2019 rckt Grant Funds Offset Against Research And Development Expenses
GrantFundsOffsetAgainstResearchAndDevelopmentExpenses
1200000
CY2021 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
CY2019 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
CY2020 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
CY2021 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-100000
CY2020 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-100000
CY2019 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
100000
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2019 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2020 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="display:none;"><br/></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-style: italic; text-indent: 27pt;">Reclassifications</div> <div style="display:none;"><br/></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-style: italic; text-indent: 27pt;"> <br/> </div> <div style="display:none;"><br/></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-indent: 27pt;">Certain reclassifications have been made to the prior year financial statements in order to conform to the current year’s presentation.</div>
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
27522000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
21252000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5223000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2046000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22299000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19206000
CY2021 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
3200000
CY2020 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
1100000
CY2019 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
400000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021 rckt Common Stock Voting Rights Number Of Votes Per Share
CommonStockVotingRightsNumberOfVotesPerShare
1
CY2021Q4 rckt Research And Development Costs Current
ResearchAndDevelopmentCostsCurrent
12082000
CY2020Q4 rckt Research And Development Costs Current
ResearchAndDevelopmentCostsCurrent
14962000
CY2021Q4 us-gaap Construction Payable Current
ConstructionPayableCurrent
725000
CY2020Q4 us-gaap Construction Payable Current
ConstructionPayableCurrent
1756000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4533000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4875000
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
0
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1122000
CY2021Q4 us-gaap Regulatory Liability Current
RegulatoryLiabilityCurrent
597000
CY2020Q4 us-gaap Regulatory Liability Current
RegulatoryLiabilityCurrent
590000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1196000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1332000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
482000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
835000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
19615000
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
25472000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.005
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.021
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
29237000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18567000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13371000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
29237000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18567000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13371000
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
46300000
CY2020Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
30400000
CY2021 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y9M18D
CY2020 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y1M6D
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1218038
CY2021 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
12800000
CY2020 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
26600000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
7051
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-169069000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-139700000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-77270000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63235417
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63235417
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55380740
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55380740
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49010358
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49010358
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.67
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.67
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.52
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.52
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.58
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.58
CY2020 rckt Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock Units Exercisable For Common Shares
IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedStockUnitsExercisableForCommonShares
0
CY2019 rckt Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock Units Exercisable For Common Shares
IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedStockUnitsExercisableForCommonShares
0
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
11143761
CY2021 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1218038
CY2020 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
610437
CY2019 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
14102
CY2021 rckt Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock Units Exercisable For Common Shares
IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedStockUnitsExercisableForCommonShares
23500
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
11050931
CY2019 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
9608537
CY2021 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
12385299
CY2020 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
13017353
CY2019 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
11243587
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
7406000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3896000
CY2021Q4 rckt Deferred Tax Liability Debt Discount
DeferredTaxLiabilityDebtDiscount
0
CY2020Q4 rckt Deferred Tax Liability Debt Discount
DeferredTaxLiabilityDebtDiscount
748000
CY2019Q4 rckt Deferred Tax Liability Debt Discount
DeferredTaxLiabilityDebtDiscount
1460000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.130
CY2020 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.000
CY2019 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.000
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.001
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.001
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.174
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.015
CY2020 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.009
CY2019 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.007
CY2021 rckt Effective Income Tax Rate Reconciliation Transfer Pricing Adjustments
EffectiveIncomeTaxRateReconciliationTransferPricingAdjustments
-0.228
CY2021Q4 rckt Deferred Tax Assets Warrants
DeferredTaxAssetsWarrants
8382000
CY2020Q4 rckt Deferred Tax Assets Warrants
DeferredTaxAssetsWarrants
5585000
CY2019Q4 rckt Deferred Tax Assets Warrants
DeferredTaxAssetsWarrants
0
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
8881000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1189000
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
643000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
93361000
CY2020 rckt Effective Income Tax Rate Reconciliation Transfer Pricing Adjustments
EffectiveIncomeTaxRateReconciliationTransferPricingAdjustments
0.000
CY2019 rckt Effective Income Tax Rate Reconciliation Transfer Pricing Adjustments
EffectiveIncomeTaxRateReconciliationTransferPricingAdjustments
0.000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.046
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.350
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.051
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.087
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.135
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.002
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
100583000
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021Q4 rckt Deferred Tax Assets Tax Credit Carryforwards Research And Development
DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopment
35766000
CY2020Q4 rckt Deferred Tax Assets Tax Credit Carryforwards Research And Development
DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopment
42613000
CY2019Q4 rckt Deferred Tax Assets Tax Credit Carryforwards Research And Development
DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopment
18471000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
26789000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
21359000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2517000
CY2021Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
19753000
CY2020Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
23179000
CY2019Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
27652000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
11552000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
51719000
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-7200000
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
48900000
CY2021Q4 rckt Annual Limitations Under Section382 Of The Internal Revenue Code Amount
AnnualLimitationsUnderSection382OfTheInternalRevenueCodeAmount
1700000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2019 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
900000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
645000
CY2021 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
2140000
CY2021Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
1791000
CY2021Q4 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
1856000
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2019Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
0
CY2021 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
1200000
CY2020 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
1100000
CY2021 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1845000
CY2021 us-gaap Lease Cost
LeaseCost
4630000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
917000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
548000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
269000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
64000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
54000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1852000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
84000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1768000
CY2021Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
1689000
CY2021Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
1736000
CY2021Q4 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
1912000
CY2021Q4 rckt Finance Lease Liability Payments Due After Year Four
FinanceLeaseLiabilityPaymentsDueAfterYearFour
45000000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
905000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1768000
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
48480000
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1689000
CY2021Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
53984000
CY2021Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
33151000
CY2021Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
20833000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1569000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
863000
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
19144000
CY2021Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
20833000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
655000
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1644000
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y6M
CY2021Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P22Y8M12D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0446
CY2021Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0896
CY2021 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.04
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
600000
CY2020 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
300000
CY2019 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
200000

Files In Submission

Name View Source Status
0001140361-22-007036-index-headers.html Edgar Link pending
0001140361-22-007036-index.html Edgar Link pending
0001140361-22-007036.txt Edgar Link pending
0001140361-22-007036-xbrl.zip Edgar Link pending
brhc10034550_10k.htm Edgar Link pending
brhc10034550_10k_htm.xml Edgar Link completed
brhc10034550_ex10-10.htm Edgar Link pending
brhc10034550_ex10-12.htm Edgar Link pending
brhc10034550_ex10-26.htm Edgar Link pending
brhc10034550_ex10-27.htm Edgar Link pending
brhc10034550_ex21-1.htm Edgar Link pending
brhc10034550_ex23-1.htm Edgar Link pending
brhc10034550_ex31-1.htm Edgar Link pending
brhc10034550_ex31-2.htm Edgar Link pending
brhc10034550_ex32-1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image01.jpg Edgar Link pending
image02.jpg Edgar Link pending
image03.jpg Edgar Link pending
image04.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
rckt-20211231.xsd Edgar Link pending
rckt-20211231_cal.xml Edgar Link unprocessable
rckt-20211231_def.xml Edgar Link unprocessable
rckt-20211231_lab.xml Edgar Link unprocessable
rckt-20211231_pre.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending